Health-Ecore news

Read our latest updates here.

2 min read

Adjuvanted influenza vaccine is a cost-effective investment for older adults in the Netherlands

Replacing standard-dose with adjuvanted influenza vaccination in adults aged 60 and over, and in high-risk adults aged 50–59, could prevent hundreds of hospitalisations and deaths per season, at an incremental cost well within accepted Dutch...

Read More

2 min read

High-dose influenza vaccination remains a cost-effective investment for older adults in the Netherlands

Updated health-economic evidence, drawing on data from more than 85 million individuals, confirms that switching from standard-dose to high-dose...

Read More

1 min read

A Coalition of the Doing: First Steps Toward Structural Data Exchange in Healthcare

Despite a growing number of data infrastructures and increasing data initiatives, secondary use of data in healthcare remains structurally...

Read More

2 min read

What Delayed RSV Vaccination Is Costing the Netherlands

Every winter, the Respiratory Syncytial Virus (RSV) fills hospital wards. Around 6,000 older adults are admitted with RSV infection in the...

Read More

3 min read

Facilitating Investments in Obesity Prevention and Treatments

Health-Ecore colleagues Bart Slob and Lisa de Jong attended the European Congress of Obesity (ECO) in Istanbul and had the chance to present their...

Read More

2 min read

The Value of Efforts to Increase Vaccination Uptake in the Netherlands

Vaccination prevents disease, reduces societal costs, and, when coverage is high enough, eliminates the threat of outbreaks entirely. Yet in the...

Read More

2 min read

Mapping the Growing Role of Informal Care

Estimates suggest that between 1.8 and 5 million informal caregivers are active in the Netherlands, ranging from individuals providing long‑term,...

Read More

2 min read

Sharing Insights at ISPOR Europe 2025: Our Poster Highlights

9–12 November 2025 | Health-Ecore at ISPOR Europe 2025, Glasgow

Read More

2 min read

Health-Ecore and MedEngine Join Forces to Advance Market Access and Real-World Evidence Across Europe

Helsinki, November 4, 2025 — Health-Ecore and MedEngine are joining forces in a new collaboration to enhance market access and real-world evidence...

Read More

1 min read

When AI Meets Systematic Reviews and Shapes the Future of Evidence Synthesis

Imagine a researcher at their desk, surrounded by hundreds of open articles, spreadsheets filled with study data, and the constant ticking of...

Read More

Cover photo: Chris Bonis